OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis
Ivan T. Lee, Raffael Nachbagauer, David J. Ensz, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 57
Ivan T. Lee, Raffael Nachbagauer, David J. Ensz, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 57
Showing 51-75 of 57 citing articles:
MULTIFACETED VIRUS-LIKE PARTICLES: NAVIGATING TOWARDS BROADLY EFFECTIVE INFLUENZA A VIRUS VACCINES
Jaffar Ali Muhamad Norizwan, Wen Siang Tan
Current Research in Microbial Sciences (2024) Vol. 8, pp. 100317-100317
Open Access
Jaffar Ali Muhamad Norizwan, Wen Siang Tan
Current Research in Microbial Sciences (2024) Vol. 8, pp. 100317-100317
Open Access
Impact of Immunosenescence on Vaccine Immune Responses and Countermeasures
Li Chen, Chengwei Shao, Jingxin Li, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1289-1289
Open Access
Li Chen, Chengwei Shao, Jingxin Li, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1289-1289
Open Access
Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
Ziqi Cheng, Junfeng Ma, Chenyan Zhao
Vaccines (2024) Vol. 12, Iss. 12, pp. 1382-1382
Open Access
Ziqi Cheng, Junfeng Ma, Chenyan Zhao
Vaccines (2024) Vol. 12, Iss. 12, pp. 1382-1382
Open Access
mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases
Rossella Brandi, Alessia Paganelli, Raffaele D’Amelio, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1418-1418
Open Access
Rossella Brandi, Alessia Paganelli, Raffaele D’Amelio, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1418-1418
Open Access
Estimates of Seasonal Influenza Burden That Could Be Averted by Improved Influenza Vaccines in the Australian Population Aged Under 65 Years, 2015–2019
Alicia Stein, Catherine GA Pendrey, David Muscatello, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 4
Open Access
Alicia Stein, Catherine GA Pendrey, David Muscatello, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 4
Open Access
An influenza mRNA vaccine protects ferrets from lethal infection with highly pathogenic avian influenza A(H5N1) virus
Masato Hatta, Yasuko Hatta, Angela Choi, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 778
Closed Access
Masato Hatta, Yasuko Hatta, Angela Choi, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 778
Closed Access
Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen
David Verhoeven, Brett A. Sponseller, James E. Crowe, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
David Verhoeven, Brett A. Sponseller, James E. Crowe, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Recombinant Ranpirnase enhances the expression of co-transfected mRNA by modulating cellular metabolic activity
Xiujin Wu, Chen Liang, Yingxue Lei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Xiujin Wu, Chen Liang, Yingxue Lei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
